SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007408
Filing Date
2022-05-04
Accepted
2022-05-04 16:31:14
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-20220331.htm   iXBRL 10-Q 1717520
2 EX-31.1 oncr-ex31_1.htm EX-31.1 18630
3 EX-32.1 oncr-ex32_1.htm EX-32.1 11013
  Complete submission text file 0000950170-22-007408.txt   6886535

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220331.xsd EX-101.SCH 43931
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220331_lab.xml EX-101.LAB 375970
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncr-20220331_cal.xml EX-101.CAL 38302
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncr-20220331_def.xml EX-101.DEF 156579
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220331_pre.xml EX-101.PRE 294506
55 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220331_htm.xml XML 1393001
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 22892013
SIC: 2834 Pharmaceutical Preparations